Nanotargeted Radionuclides for Cancer Nuclear Imaging and Internal Radiotherapy

Table 1

Characteristics of potential radionuclides for nanotargeted tumor imaging [20, 21, 28, 29].

Radionuclide	Production	Emission type	Half-life	𝐸max(𝛾), (keV)
^131I	^130I(n, 𝛾)^131Te (𝛽) ^131I	𝛾 (81.2%), 𝛽	8.0 days	284, 364, 637
^67Ga	^68Zn (n, p)^67Ga	𝛾	78.3 h	93, 184, 300, 393
^111In	^111Cd (p, n)^111In	Auger, 𝛾	67.2 h	171, 245
^123I	^121Sn (𝛼, 2n)^123I	Auger, 𝛾	13.2 h	159
^99mTc	^99Mo/^99mTc-generator	𝛾	6.0 h	140
^18F	^18O (p, n)^18F	Positron	1.83 h	𝐸𝛽+ 635
^64Cu	^64Ni(p, n)^64Cu	Positron	12.7 h	𝐸𝛽+ 656
^76Br	^76Se(p, n)^76Br	Positron	16.0 h	𝐸𝛽+ 3941
^124I	^124Te(p, n)^124I	Positron	100.2 h	𝐸𝛽+ 2134, 1533